Opinion|Videos|December 3, 2024
Addressing Challenges in Accessing Traditional STI Screening Options
Author(s)Kameelah Phillips, MD, FACOG, NCMP
The panelist discusses how asymptomatic sexually transmitted infections (STIs) can silently impact overall health, emphasizing the importance of comprehensive screening and education, particularly for less known STIs like trichomoniasis and Mycoplasma genitalium, while exploring how newer testing methods like nucleic acid amplification testing (NAAT) can address challenges in traditional screening access and improve patient care.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- In what ways can asymptomatic STIs impact overall health, and why is screening important?
- How can health care providers effectively raise awareness about less commonly known STIs like trichomoniasis and Mycoplasma genitalium?
- What challenges do patients face when accessing traditional STI screenings testing, and how can these be addressed?
- How does the use of newer screening methods like NAAT impact patient access to necessary screenings?
Advertisement
Related to this article
Hugh Taylor, MD, outlines a stepwise approach to endometriosis therapy, from first-line oral contraceptives to oral GnRH antagonists for progestin-resistant patients.
Hosted by Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, the monthly series brings clinicians, researchers, innovators, advocates, and other voices across women’s health into conversations that rarely happen in the same room.
A new book from Sameena Rahman, MD, reclaims "brown girls' disease" as a lens for examining how dismissal—of conditions, anatomy, and patients—undermines sexual medicine care for all women.
Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.
The FDA approved an IDE allowing Mercy BioAnalytics to evaluate its Evident blood-based ovarian cancer screening test in the prospective pivotal SOARA study of average-risk women.
Sameena Rahman, MD, discusses how digital symptom trackers can shorten PMOS diagnostic delays and support earlier cardiometabolic care.
A new, expert-led video series explores the PCOS-to-PMOS rename and what it means for diagnosis, care, and outcomes.
Seventy-one percent of women miss their first perimenopausal symptom because anxiety, brain fog, and mood changes precede hot flashes—and most attribute them to stress, per the Bonafide 2026 State of Menopause Survey.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Contemporary OB/GYN launches 'Missed & Dismissed' podcast to explore diagnostic gaps in women's health
2
Zuranolone shows sustained PPD symptom improvement through day 90
3
Hugh Taylor, MD, discusses first- and second-line medical therapy for endometriosis
4
Sameena Rahman, MD, on bias, dismissed diagnoses, and the vulvar vestibule
5